%e2%80%8eblog graphics.%e2%80%8e001
By Nucleati Team

PHOX2B Germline Mutation and Neuroblastoma: Genetic Evidence

In the intricate realm of genetics, certain master regulators hold the key to developing and functioning critical systems within our bodies. One such transcription factor is PHOX2B.

Read more
%e2%80%8eblog graphics.%e2%80%8e001
By Nucleati Team

EPAS1 Mutations and Paraganglioma Insights from Recent Genetic Evidence

Paraganglioma, a rare neuroendocrine tumor, has long fascinated scientists and medical geneticists due to its enigmatic nature and potential genetic predisposition. Recent case reports in medical genetics have shed light on the connection between paraganglioma and mutations in the EPAS1 gene, which encodes the hypoxia-inducible factor 2-alpha (HIF-2α).

Read more
%e2%80%8eblog graphics.%e2%80%8e001
By Nucleati Team

Association between Pathogenic Mutations in SMARCE1 and Meningioma: Summary of Case Reports and Multi-Patient Studies.

Read more
Blog graphics.001
By Nucleati Team

Summary of evidence associating CTNNA1 and Stomach/Gastric Cancer

Hereditary diffuse gastric cancer syndrome (HDGC) is often linked with a heightened risk of diffuse gastric cancer and lobular breast cancer, usually resulting from germline pathogenic variants in the CDH1 gene.

Read more
Functionalassays
By Nucleati Team

Functional Evidence: A Comprehensive Guide for Variant Classification and Gene Validity Assessment

Genetic variant classification and establishing gene-disease associations are essential in clinical genetics and precision medicine. Functional assays, which assess the impact of genetic variants on gene and protein function, play a crucial role in these processes.

Read more
Blog graphics.001
By Nucleati Team

Association of SBDS Gene Mutations with Acute Myeloid Leukemia: A Comprehensive Review and Analysis of Genetic Evidence

The association between the SBDS gene and acute myeloid leukemia (AML) has been a topic of growing interest in recent years. Shwachman-Diamond syndrome (SDS), a rare inherited disorder caused by mutations in the SBDS gene, has been linked to an increased risk of developing AML.

Read more
Blog graphics.001
By Nucleati Team

Evidence for associations of EXT1/EXT2 Gene Mutations and Chondrosarcoma: A Review of Medical Genetics Studies.

The EXT1 and EXT2 genes have long been recognized for their association with hereditary multiple exostoses (HME), a genetic disorder characterized by the presence of multiple benign bone tumors called osteochondromas.

Read more
Blog graphics.001
By Nucleati Team

DIS3L2 Mutations and Predisposition to Nephroblastoma: Evidence of Associations Through Patient Cases and Cohort Studies

Nephroblastoma, commonly known as Wilms tumor, poses a significant health challenge in pediatric oncology.

Read more
Blog graphics.001
By Nucleati Team

RECQL4 Mutations and Osteosarcoma: Comprehensive Genetics Evidence

Osteosarcoma, a malignant bone tumor primarily affecting children and adolescents, has long been associated with genetic factors.

Read more
Blog graphics.001
By Nucleati Team

Exploring the Association between PTPN11 Mutations and Diverse Medical Outcomes, including hematological malignancies and neuroblastoma.

In the realm of genetic research, understanding the implications of specific gene mutations is paramount to unraveling the mysteries of various medical conditions. One such gene of interest is PTPN11, known for its association with a diverse array of outcomes.

Read more